Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China
· Delayed Price · Currency is CNY 18.42
-0.49 (-2.59%)
Apr 29, 2026, 3:04 PM CST
SHE:002317 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 16,072 | 16,132 | 10,279 | 13,607 | 21,822 | 9,641 | Upgrade
|
| Market Cap Growth | 73.50% | 56.94% | -24.46% | -37.64% | 126.34% | 8.90% | Upgrade
|
| Enterprise Value | 15,322 | 15,382 | 8,899 | 12,528 | 21,472 | 9,286 | Upgrade
|
| Last Close Price | 18.91 | 18.98 | 11.96 | 15.58 | 25.88 | 11.45 | Upgrade
|
| PE Ratio | 57.30 | 58.50 | - | 51.69 | 67.76 | 34.73 | Upgrade
|
| Forward PE | - | 16.57 | 16.57 | 16.57 | 16.57 | 16.57 | Upgrade
|
| PS Ratio | 6.37 | 6.40 | 4.17 | 5.21 | 8.15 | 3.97 | Upgrade
|
| PB Ratio | 3.90 | - | 2.56 | 3.01 | 5.72 | 2.73 | Upgrade
|
| P/TBV Ratio | 4.58 | - | 2.87 | 3.68 | 6.75 | 3.21 | Upgrade
|
| P/FCF Ratio | - | - | 93.80 | - | - | 23.57 | Upgrade
|
| P/OCF Ratio | 52.66 | 52.86 | 30.43 | 71.39 | 345.99 | 15.48 | Upgrade
|
| PEG Ratio | - | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | Upgrade
|
| EV/Sales Ratio | 6.07 | 6.10 | 3.61 | 4.80 | 8.02 | 3.82 | Upgrade
|
| EV/EBITDA Ratio | 34.40 | 34.72 | 27.59 | 26.94 | 44.93 | 20.08 | Upgrade
|
| EV/EBIT Ratio | 47.79 | 47.98 | 43.00 | 36.19 | 56.44 | 25.22 | Upgrade
|
| EV/FCF Ratio | -1397.19 | - | 81.21 | - | - | 22.71 | Upgrade
|
| Debt / Equity Ratio | - | - | 0.08 | 0.16 | 0.24 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.94 | 1.55 | 1.88 | 1.11 | Upgrade
|
| Debt / FCF Ratio | - | - | 2.79 | - | - | 1.26 | Upgrade
|
| Net Debt / Equity Ratio | - | - | -0.39 | -0.35 | -0.14 | -0.22 | Upgrade
|
| Net Debt / EBITDA Ratio | - | - | -4.85 | -3.44 | -1.08 | -1.68 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -14.27 | 9.28 | 2.53 | -1.90 | Upgrade
|
| Asset Turnover | - | - | 0.41 | 0.43 | 0.50 | 0.50 | Upgrade
|
| Inventory Turnover | - | - | 2.36 | 2.16 | 2.02 | 1.90 | Upgrade
|
| Quick Ratio | - | - | 2.43 | 3.30 | 2.39 | 4.01 | Upgrade
|
| Current Ratio | - | - | 2.88 | 3.90 | 2.92 | 5.10 | Upgrade
|
| Return on Equity (ROE) | - | - | -8.76% | 5.99% | 8.58% | 7.67% | Upgrade
|
| Return on Assets (ROA) | - | - | 2.15% | 3.54% | 4.45% | 4.75% | Upgrade
|
| Return on Invested Capital (ROIC) | - | 23.57% | 7.70% | 9.80% | 10.76% | 11.95% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 4.80% | 6.40% | 8.20% | 8.40% | Upgrade
|
| Earnings Yield | 1.72% | 1.71% | -2.91% | 1.93% | 1.48% | 2.88% | Upgrade
|
| FCF Yield | -0.07% | -0.07% | 1.07% | -1.27% | -0.94% | 4.24% | Upgrade
|
| Dividend Yield | 1.04% | - | 1.67% | 1.28% | 0.77% | 1.75% | Upgrade
|
| Payout Ratio | 61.76% | 61.76% | - | 65.15% | 56.33% | 67.30% | Upgrade
|
| Buyback Yield / Dilution | -0.56% | -0.56% | -1.00% | -2.19% | -1.50% | 1.45% | Upgrade
|
| Total Shareholder Return | 0.48% | -0.56% | 0.67% | -0.90% | -0.73% | 3.20% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.